r

Colombia still faces challenges to improve health care quality

Colombia has significantly improved its health system over the past 20 years, leading to a rise in life expectancy and a fall in infant mortality. To maintain its ambition of universal, high-quality health care, Colombia should now focus on improving efficiency and strengthening financial sustainability, according to a new OECD report.




r

The Mexican health care system has made great progress during the last decade – but the remaining challenges are daunting

In the ten years since the introduction of Seguro Popular, some 50 million Mexicans previously at risk of unaffordable health care bills now have access to health insurance. The OECD Review of Health Systems: Mexico 2016 finds that the share of the population exposed to unaffordable or impoverishing health care costs has fallen from 3.3% to 0.8% of the population in the past decade.




r

World Cancer Day: Where do OECD countries stand in the “war against cancer”?

World Cancer Day: Where do OECD countries stand in the “war against cancer”?




r

Overview of Health Policy in Australia

The Australian health system is a complex mix of federal and state government funding and responsibility, making it difficult for patients to navigate. Despite its complexity, Australia’s universal health system achieves good results relatively efficiently.




r

Overview of Health Policy in Canada

The growth rate in health spending per capita in Canada has slowed down markedly in recent years, being close to zero in real terms since 2011. Life expectancy in Canada is one year higher than the OECD average, but rising alcohol consumption and obesity rates are growing risk factors to health. Canada could further improve the quality of care in order to cope better with rising prevalence of chronic diseases.




r

Overview of Health Policy in Finland

Finland appears to have a high performing health system, with remarkable good quality in both primary and hospital care. The country also achieves good health status at relatively low level of health spending. Despite these advances, there are specific areas where improvements can be made such as preventing the spread of obesity and addressing gaps in mental health.




r

Overview of Health Policy in France

The French health care system performs relatively well. Health outcomes are better than the OECD average and citizens enjoy good access to care. However, France is lagging behind other OECD countries in some areas including for example antibiotics prescribing or alcohol consumption.




r

Overview of Health Policy in Italy

Italy’s indicators of health system outcomes and quality are consistently good. This is despite levels of health spending below other high-income OECD countries. However, Italy is lagging behind in some areas, like long-term care and prevention of non-communicable diseases.




r

Private hospital prices in South Africa are expensive for citizens

Price levels for private hospital services in South Africa are comparable to the levels observed across OECD countries. But they are higher than what could be expected given the country’s income, according to a new OECD working paper.




r

Urgent research needed into risks from nanomaterials in household waste

Urgent research is needed to assess the possible risks to human health and ecosystems from the ever-increasing amounts of engineered nanomaterials going into household waste and ending up in the environment, according to a new OECD report.




r

Overview of Health Policy in Ireland

Although Ireland has seen remarkable improvements in the health of its population in the last decades, several challenges lie ahead for its health system. Based on available OECD analyses, further progress could be made to promote efficient use of hospital resources, strengthen primary care, address high pharmaceutical spending and prevent the spread of risk factors including obesity and alcohol consumption.




r

Overview of Health Policy in Chile

Despite achieving near universal health coverage with a basic benefit package that all health payers must provide, health financing in Chile remains inefficient and inequitable. There is room for improving the system by moving towards a unified, equitable social security system for the entire population.




r

Overview of Health Policy in Mexico

Although many health indicators are improving in Mexico, the country has the lowest life expectancy in the OECD. This is due to unhealthy lifestyles with higher risk factors to health leading to chronic diseases and mortality, but also to persisting barriers of access to high-quality health care services.




r

Overview of Health Policy in Belgium

Belgium shows average health outcomes compared to other OECD countries. Life expectancy at birth is 80.7 years, just above the OECD average. Quality of care is fair, standing again near the OECD average. Health expenditure at 10.2% of GDP is higher than the OECD average of 1.3% points in 2013. Health policy in Belgium relies on shared responsibility of both the federal authorities and federated entities (regions and communities).




r

Health workers with right skills in right places needed

The number of doctors and nurses has reached record levels in the OECD. Countries should now reform their training and employment strategies to better respond to people’s changing health needs and also reduce their reliance on foreign-trained health workers from developing countries, according to a new OECD report.




r

The doctor will see you now (if you turn on the video)

An elderly man with cardiovascular disease tests his own blood pressure, and sends the results to an online application that his doctor can access. Another patient with depression living in a rural area far from health services tells a psychiatrist how he is feeling via a video connection. All of this occurs without the patients leaving their homes.




r

Pharmaceutical Expenditure and Policies: Past Trends and Future Challenges

This paper looks at recent trends in pharmaceutical spending across OECD countries. It examines the drivers of recent spending trends, highlighting differences across therapeutic classes, and then looks at emerging challenges for policy makers in the management of pharmaceutical spending.




r

Overview of Health Policy in Greece

Between 2009 and 2013, public spending on health fell by EUR 5.2 billion – representing a 32% drop in real-terms. This reduction clearly represents a shock for the system to adsorb, even though it is clear that there were inefficiencies in the Greek system (for example, inappropriate prescribing, weak primary care, imbalances in the mix of health professionals).




r

Overview of Health Policy in Norway

Norway has an impressive and comprehensive health system, but it is facing several challenges over the coming years. The shift in the need for care from an ageing population will weigh heavily on the Norwegian health care system, demanding for more skilled health care personnel as well as strengthening of community care.




r

Overview of Health Policy in Israel

Israel has built a universal health system at relatively low-cost. Health spending was 7.5% of GDP in 2013, below the OECD average of 8.9% although the health spending share of GDP has been increasing rapidly, particularly in recent years. Israel has developed a sophisticated programme to monitor quality of primary care.




r

Overview of Health Policy in Korea

In the past 30 years Korea has gone from having a limited medical infrastructure, fragmented financing and limited population coverage, to a health care system characterised by universal coverage, one of the highest life expectancies in the world while still having one of the lowest levels of health expenditure among OECD countries.




r

Air pollution to cause 6-9 million premature deaths and cost 1% GDP by 2060

Outdoor air pollution could cause 6 to 9 million premature deaths a year by 2060 and cost 1% of global GDP – around USD 2.6 trillion annually – as a result of sick days, medical bills and reduced agricultural output, unless action is taken, according to a new OECD report.




r

Tackling antimicrobial resistance

At the OECD, we have calculated that about 50% of all the antimicrobials prescribed by healthcare facilities in our member countries do not meet prescription guidelines. In healthcare services such as long-term care facilities and general practices up to 70% and 90% respectively of antibiotics may be prescribed for inappropriate reasons.




r

OECD Health Ministerial

On 16-17 January 2017, the OECD will host a meeting for Ministers of Health and a High-Level Policy Forum on person-centred care, at the OECD Headquarters in Paris.




r

Health Systems Characteristics

Responses from the third wave of the OECD Health System Characteristics Survey are available online, providing access to the most recent information on key institutional characteristics of health systems of OECD countries and key partner and accession countries.




r

Launch event of the report “Working for health and growth: investing in the health workforce”: closing remarks by Angel Gurría

The High-Level Commission on Health Employment and Economic Growth, chaired by H.E. François Hollande and H.E. Jacob Zuma, today delivered its final report and recommendations to United Nations Secretary General Ban Ki-moon on the sidelines of the UN General Assembly in New York.




r

Latvia faces important challenges to improve the performance of its health system

Latvia has successfully consolidated its hospital sector and strengthened primary care since the financial crisis. But persistent barriers to accessing high quality care need to be removed, according to a new OECD report.




r

G7 Health Ministers meeting in Kobe on 11-12 September 2016 recognises OECD work

The G7 Health Ministers meeting in Kobe on 11-12 September welcomed OECD work on the linkages between Universal Health Coverage and healthy ageing, and recognised OECD work on access to innovative health treatments. The OECD will deliver initial findings following the French-led initiative to identify innovative options to pay for new medicines and high-cost treatments at the 17 January 2016 OECD Health Ministers meeting.




r

Europe paying a heavy price for chronic diseases, finds new OECD-EC report

Better public health and prevention policies as well as more effective health care could save hundreds of thousands of lives and billions of euros each year in Europe, according to a new joint OECD/European Commission report.




r

New approach needed to tackle rising drug prices

The proliferation of high-cost medicines and rising drug prices are increasing pressures on public health spending and calling into question the pharmaceutical industry’s pricing strategies.




r

Policy Forum on the Future of Health

This High-Level Forum will be held at the OECD Conference Centre in Paris on 16 January 2017. Issues include: Harnessing digital technology and data to create proactive, people-centred systems; Overcoming technical, institutional and cultural challenges; Caring for people with complex needs; The importance of measuring what matters to people and to patients, and The role of international and cross-sector collaboration.




r

OECD Health Ministerial Statement 2017

OECD Health Ministers meeting in Paris have underlined their commitment to tackling important challenges facing health systems around the world. E.g. improving the delivery of high-quality care for all; addressing how to pay for effective health technologies; measuring health system performance on the basis of what it delivers to people, as well as making better use of health data; and making health systems more people-centred.




r

Graph of the Month

The OECD Health Division is releasing a new series to highlight its work on health policies and data. A new graph will be available each month.




r

Sustained reforms are essential to reinforcing inclusive growth in Italy

Italy is slowly emerging from a deep and lengthy recession, helped by a range of structural reforms – such as the Jobs Act – and accommodative monetary and fiscal policies, according to a new OECD report.




r

Sustainable access to innovative therapies - Online consultation

The OECD is launching an online consultation: tell us how we can improve sustainable access to innovative therapies!




r

OECD Newsletter on Health, Employment, Migration and Social Affairs

Read about our groundbreaking report on inequality - In it Together: Why less inequality benefits all - as well as our recent work on tackling harmful alcohol use. You can also find here all our work on employment, migration, health and social policy over the last few months, as well as highlights from this summer's OECD Forum which addressed the theme "Investing in the future: people, planet, prosperity”.




r

Output-based hospital-specific Purchasing Power Parities

Purchasing Power Parities (PPPs) are commonly used to convert national currencies to a common unit. The main novel feature in the 2017 report is the collection of comparable and output-based prices for hospital services that can then be applied to matching health accounts expenditure data so as to derive consistent price and volume comparisons of health and hospital goods and services consumed.




r

Universal Health Coverage

Universal Health Coverage is about everyone having access to good quality health services without suffering financial hardship. Although most OECD countries offer all their citizens affordable access to a comprehensive package of health services, they face challenges in sustaining and enhancing such universal systems.




r

The microbiome, diet and health: Towards a science and innovation agenda

There is now strong evidence that microbiomes play an important role in human health, as there are clear linkages to many major non-communicable diseases. This report assesses the key policy challenges for innovation in the microbiome. It argues that if such a promising scientific field is to lead to innovative applications, policies on science and innovation must be improved in five areas.




r

Marine biotechnology: Definitions, infrastructures and directions for innovation

Several countries have been setting up strategic roadmaps to support marine biotechnologies that could drive innovation and help address the global sustainability goals of food, energy, and health. This report identifies and begins to address challenges facing cooperation on marine biotechnology across countries.




r

Mental Health Systems in OECD Countries

Mental disorders represent a considerable disease burden, and have a significant impact on the lives of the OECD population, and account for considerable direct and indirect costs. This report argues that even in those OECD countries with a long history of deinstitutionalisation, there is still a long way to go to make community-based mental health care that achieves good outcomes for people with severe mental illness a reality.




r

World Health Summit 2017: OECD presenting on Big Data

World Health Summit 2017: OECD presenting on Big Data




r

Public Health Reviews

This new series of OECD Reviews of Public Health provide in-depth analysis and policy recommendations to strengthen priority areas of countries’ public health systems, highlighting best practice examples that allow learning from shared experiences, and the spreading of innovative approaches.




r

Key biotechnology indicators

Statistics on biotechnology firms, biotechnology R&D (including public sector expenditures), biotech applications and patents.




r

Healthier lifestyles and better health policies drive life expectancy gains

Healthier lifestyles, higher incomes and better education have all contributed to boost life expectancy in recent decades. Better health care has also helped, according to a new OECD report.




r

Country Health Profiles 2017

The Country Health Profiles are an important step in the European Commission’s two-year State of Health in the EU cycle and are the result of joint work between the OECD and the European Observatory on Health Systems and Policies. The concise, policy relevant profiles are based on a transparent, consistent methodology, using both quantitative and qualitative data, yet flexibly adapted to the context of each EU Member State.




r

Neurotechnology and society: Strengthening responsible innovation in brain science

This report identifies, and seeks to address, key challenges for the responsible development of neurotechnology. In particular, it analyses frameworks and mechanisms for integrating social concerns in the early development of technology, and discusses best practices for research funders across the public and private sector.




r

Health Update - The OECD Newsletter on Health

Read about the release of Health at a Glance 2017, of the 28 EU Country Health Profiles, and of other major reports such as Preventing Ageing Unequally and our Costa Rica and Peru OECD Reviews of Health Systems. The Health Division also prepared for the Milan G7 Health Ministers’ Meeting a brochure on "Healthy people, healthy planet". Also access our latest Health Working Papers.




r

Antimicrobial Resistance

Antimicrobial resistance is a growing health and economic threat requiring multipronged responses. The OECD provides a forum for discussion and provide countries with the evidence to implement effective and cost-effective policies to tackle AMR, promote effective use of antimicrobials and incentivise research and development in the antibiotic sector.




r

OECD Work on Health - Brochure

This new brochure presents the OECD Work on Health for 2017-2018, including all recent and forthcoming major publications and databases.